August 3, 2025
Financière de Tubize – 2025 half-year financial report
Half-year financial report 2025Regulated information 2 August 2025 The board of directors of Financière de Tubize has established the 2025…
Pharmaceuticals, Biotechnology and Life Sciences
Half-year financial report 2025Regulated information 2 August 2025 The board of directors of Financière de Tubize has established the 2025…
DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology…
VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (“Sirona”) wishes to provide…
LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (Coherus, Coherus Oncology or the Company, Nasdaq: CHRS), today…
Strengthening technology innovation and leadership of the Certara AI/ML-enabled biosimulation platform used to speed time to market in drug discovery…
BALA CYNWYD, Pa., July 31, 2025 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused…
REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep,…
Webcast Scheduled for Thursday, August 7 at 4:30 p.m. EasternCHASKA, Minn., July 31, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc.…
CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…